Adverse-Event Reporting Failure Leads To Guilty Plea For Olympus, Exec
Executive Summary
Olympus Medical Systems and a former senior executive have pleaded guilty to allegations that they sold duodenoscopes even after failing to submit required adverse-event reports on them.
You may also be interested in...
No Prison Time For Former Olympus Exec In Scope Case
A former Olympus exec who took personal responsibility for the company’s failure to submit duodenoscope-related adverse event reports has been sentenced to one year’s probation and a $5,000 fine.
US FDA Report Confirms Duodenoscope Contamination Risk
An early look at the results of post-market studies that had been ordered by US FDA for duodenoscopes highlights ongoing sterilization issues.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.